151 related articles for article (PubMed ID: 29380864)
21. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
22. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
J Investig Allergol Clin Immunol; 2013; 23(3):141-4; quiz 2 p preceding 145. PubMed ID: 23967751
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria.
Sarti L; Barni S; Giovannini M; Liccioli G; Novembre E; Mori F
Pediatr Allergy Immunol; 2021 Jan; 32(1):153-160. PubMed ID: 32745323
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
26. [Desloratadine for chronic idiopathic urticaria].
Rottem M; Elbirt D; Sthoeger Z;
Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
[TBL] [Abstract][Full Text] [Related]
27. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
Kavosh ER; Khan DA
Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
Zuberbier T
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
32. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
Hide M; Yagami A; Togawa M; Saito A; Furue M
Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
[TBL] [Abstract][Full Text] [Related]
34. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
Liang SE; Hoffmann R; Peterson E; Soter NA
JAMA Dermatol; 2019 Jan; 155(1):90-95. PubMed ID: 30476976
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria.
Khalaf AT; Liu XM; Sheng WX; Tan JQ; Abdalla AN
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):487-92. PubMed ID: 18081747
[TBL] [Abstract][Full Text] [Related]
36. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
39. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
Sharma VK; Gupta V; Pathak M; Ramam M
J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
[TBL] [Abstract][Full Text] [Related]
40. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
